[ET Net News Agency, 4 November 2026] HANSOH PHARMA (03692) rose 5.2% to HK$33.6.
It hits an intra-day high of HK$33.6, breaking above the 100-D SMA of HK$32.578, and an intra-day low of HK$32.16. The total shares traded was 10 million, with a value of HK$327.63m. The active buy/sell ratio is 71:29, with net buying turnover of HK$133.51m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$24.58m, with volume weighted average price of HK$32.731. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$56.81m, with volume weighted average price of HK$32.82.
The Hang Seng Index now rose 294 points, or 1.3% to 23,820; the Hang Seng China Enterprises Index now rose 94 points, or 1.2% to 8,037.
Basic Information| Nominal | 33.600 | % Chg | +5.20% |
| High | 33.600 | Low | 32.160 |
| Shares Tr | 10m | Turnover | 327.63m |
| 10-D SMA | 32.470 | %H.V | 52.807 |
| 20-D SMA | 32.395 | VWAP | 32.761 |
| 50-D SMA | 33.569 | RSI14 | 53.706 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 71:29, with net buying turnover of HK$133.51m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 33.600 | +5.20 |
| SIHUAN PHARM (00460) | 0.740 | +2.78 |
| GRAND PHARMA (00512) | 4.270 | +0.59 |
| SBP GROUP (01177) | 5.100 | +4.40 |
| HENGRUI PHARMA (01276) | 50.950 | +0.10 |
| LIVZON PHARMA (01513) | 24.180 | +1.77 |
| LUYE PHARMA (02186) | 1.605 | Unchanged |
| FOSUN PHARMA (02196) | 16.930 | +0.36 |
| SH PHARMA (02607) | 11.200 | +1.17 |
| CHINARES PHARMA (03320) | 4.665 | -0.53 |
(ed)
Nominal 
